868 related articles for article (PubMed ID: 17129677)
21. Expression of p16 protein in patients with uterine smooth muscle tumors: an immunohistochemical analysis.
Bodner-Adler B; Bodner K; Czerwenka K; Kimberger O; Leodolter S; Mayerhofer K
Gynecol Oncol; 2005 Jan; 96(1):62-6. PubMed ID: 15589581
[TBL] [Abstract][Full Text] [Related]
22. Oncogenic property of acrogranin in human uterine leiomyosarcoma: direct evidence of genetic contribution in in vivo tumorigenesis.
Matsumura N; Mandai M; Miyanishi M; Fukuhara K; Baba T; Higuchi T; Kariya M; Takakura K; Fujii S
Clin Cancer Res; 2006 Mar; 12(5):1402-11. PubMed ID: 16533762
[TBL] [Abstract][Full Text] [Related]
23. Hypoxia upregulates the expression of the O-linked N-acetylglucosamine containing epitope H in human ependymal cells.
Arvanitis LD; Vassiou K; Kotrotsios A; Sgantzos MN
Pathol Res Pract; 2011 Feb; 207(2):91-6. PubMed ID: 21145174
[TBL] [Abstract][Full Text] [Related]
24. Uterine leiomyosarcomas are characterized by high p16, p53 and MIB1 expression in comparison with usual leiomyomas, leiomyoma variants and smooth muscle tumours of uncertain malignant potential.
O'Neill CJ; McBride HA; Connolly LE; McCluggage WG
Histopathology; 2007 Jun; 50(7):851-8. PubMed ID: 17543074
[TBL] [Abstract][Full Text] [Related]
25. Apoptosis, cellular proliferation and expression of p53 in human uterine leiomyomas and myometrium during the menstrual cycle and after menopause.
Wu X; Blanck A; Olovsson M; Möller B; Favini R; Lindblom B
Acta Obstet Gynecol Scand; 2000 May; 79(5):397-404. PubMed ID: 10830768
[TBL] [Abstract][Full Text] [Related]
26. Ultrastructural immunostaining of infiltrating ductal breast carcinomas with the monoclonal antibody H: a comparative study with cytokeratin 8.
Havaki S; Kittas C; Marinos E; Dafni U; Sotiropoulou C; Voloudakis-Baltatzis I; Goutas N; Vassilaros SD; Athanasiou E; Arvanitis DL
Ultrastruct Pathol; 2003; 27(6):393-407. PubMed ID: 14660278
[TBL] [Abstract][Full Text] [Related]
27. Apoptotic and cell cycle regulatory markers in uterine leiomyosarcoma.
Leiser AL; Anderson SE; Nonaka D; Chuai S; Olshen AB; Chi DS; Soslow RA
Gynecol Oncol; 2006 Apr; 101(1):86-91. PubMed ID: 16289259
[TBL] [Abstract][Full Text] [Related]
28. Epithelioid smooth muscle tumors of the uterus do not express CD1a: a potential immunohistochemical adjunct in their distinction from uterine perivascular epithelioid cell tumors.
Fadare O; Liang SX
Ann Diagn Pathol; 2008 Dec; 12(6):401-5. PubMed ID: 18995203
[TBL] [Abstract][Full Text] [Related]
29. Plasminogen activator inhibitor 1 messenger RNA expression and molecular evidence for del(7)(q22) in uterine leiomyomas.
Sourla A; Polychronakos C; Zeng WR; Nepveu A; Kukuvitis A; Naud F; Koutsilieris M
Cancer Res; 1996 Jul; 56(13):3123-8. PubMed ID: 8674071
[TBL] [Abstract][Full Text] [Related]
30. Decreased expression of early growth response-1 and its role in uterine leiomyoma growth.
Shozu M; Murakami K; Segawa T; Kasai T; Ishikawa H; Shinohara K; Okada M; Inoue M
Cancer Res; 2004 Jul; 64(13):4677-84. PubMed ID: 15231681
[TBL] [Abstract][Full Text] [Related]
31. Lessons from pregnancy and parturition: uterine leiomyomas result from discordant differentiation and dedifferentiation responses in smooth muscle cells.
Cesen-Cummings K; Walker CL; Davis BJ
Med Hypotheses; 2000 Dec; 55(6):485-90. PubMed ID: 11090295
[TBL] [Abstract][Full Text] [Related]
32. Insulin-like growth factor gene expression in human smooth muscle tumors.
Gloudemans T; Prinsen I; Van Unnik JA; Lips CJ; Den Otter W; Sussenbach JS
Cancer Res; 1990 Oct; 50(20):6689-95. PubMed ID: 2208134
[TBL] [Abstract][Full Text] [Related]
33. Ki-67 expression in patients with uterine leiomyomas, uterine smooth muscle tumors of uncertain malignant potential (STUMP) and uterine leiomyosarcomas (LMS).
Mayerhofer K; Lozanov P; Bodner K; Bodner-Adler B; Kimberger O; Czerwenka K
Acta Obstet Gynecol Scand; 2004 Nov; 83(11):1085-8. PubMed ID: 15488127
[TBL] [Abstract][Full Text] [Related]
34. MED12 exon 2 mutations in uterine and extrauterine smooth muscle tumors.
Schwetye KE; Pfeifer JD; Duncavage EJ
Hum Pathol; 2014 Jan; 45(1):65-70. PubMed ID: 24196187
[TBL] [Abstract][Full Text] [Related]
35. Increased expression of calcium-binding protein S100 in human uterine smooth muscle tumours.
Kanamori T; Takakura K; Mandai M; Kariya M; Fukuhara K; Sakaguchi M; Huh NH; Saito K; Sakurai T; Fujita J; Fujii S
Mol Hum Reprod; 2004 Oct; 10(10):735-42. PubMed ID: 15322223
[TBL] [Abstract][Full Text] [Related]
36. Oxytocin-induced cell growth proliferation in human myometrial cells and leiomyomas.
Busnelli M; Rimoldi V; Viganò P; Persani L; Di Blasio AM; Chini B
Fertil Steril; 2010 Oct; 94(5):1869-74. PubMed ID: 20056210
[TBL] [Abstract][Full Text] [Related]
37. The expression of Abl interactor 2 in leiomyoma and myometrium and regulation by GnRH analogue and transforming growth factor-beta.
Luo X; Levens E; Williams RS; Chegini N
Hum Reprod; 2006 Jun; 21(6):1380-6. PubMed ID: 16488906
[TBL] [Abstract][Full Text] [Related]
38. Estrogen-induced changes in IGF-I, Myb family and MAP kinase pathway genes in human uterine leiomyoma and normal uterine smooth muscle cell lines.
Swartz CD; Afshari CA; Yu L; Hall KE; Dixon D
Mol Hum Reprod; 2005 Jun; 11(6):441-50. PubMed ID: 15879465
[TBL] [Abstract][Full Text] [Related]
39. The Use of p16 in enhancing the histologic classification of uterine smooth muscle tumors.
Atkins KA; Arronte N; Darus CJ; Rice LW
Am J Surg Pathol; 2008 Jan; 32(1):98-102. PubMed ID: 18162776
[TBL] [Abstract][Full Text] [Related]
40. Cell proliferation and apoptosis in human uterine leiomyomas and myometria.
Dixon D; Flake GP; Moore AB; He H; Haseman JK; Risinger JI; Lancaster JM; Berchuck A; Barrett JC; Robboy SJ
Virchows Arch; 2002 Jul; 441(1):53-62. PubMed ID: 12111201
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
